{
    "2020-01-13": [
        [
            {
                "time": "2023-01-15",
                "original_text": "Novartis to speed access to $10 billion heart drug via NHS deal",
                "features": {
                    "keywords": [
                        "Novartis",
                        "heart drug",
                        "NHS deal",
                        "speed access"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-01-15",
                "original_text": "Alnylam Provides Preliminary Q4 Sales for Onpattro & Givlaari",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Q4 Sales",
                        "Onpattro",
                        "Givlaari"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-01-15",
                "original_text": "Novartis, U.K. National Health Service Partner for Trial of Cholesterol-Drug Candidate",
                "features": {
                    "keywords": [
                        "Novartis",
                        "U.K. National Health Service",
                        "Cholesterol-Drug",
                        "Trial"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-01-15",
                "original_text": "UKâ€™s NHS teams with Novartis to launch heart attack drug trial",
                "features": {
                    "keywords": [
                        "NHS",
                        "Novartis",
                        "heart attack drug",
                        "trial"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}